Brokerages Set Encompass Health Co. (NYSE:EHC) PT at $83.22

Shares of Encompass Health Co. (NYSE:EHC) have received an average recommendation of “Buy” from the eight research firms that are currently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1 year target price among brokerages that have issued a report on the stock in the last year is $88.13.

A number of research analysts have commented on EHC shares. Barclays upped their price target on Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a research note on Thursday, April 25th. Mizuho upped their price target on Encompass Health from $93.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Wednesday, February 7th. Raymond James restated a “strong-buy” rating and set a $95.00 price target (up from $85.00) on shares of Encompass Health in a research note on Friday. Finally, Truist Financial upped their price target on Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a research note on Friday, February 9th.

Encompass Health Trading Up 1.4 %

EHC opened at $83.62 on Thursday. Encompass Health has a one year low of $57.55 and a one year high of $85.84. The stock has a market capitalization of $8.37 billion, a PE ratio of 22.60, a P/E/G ratio of 1.34 and a beta of 0.94. The business’s 50 day moving average price is $78.45 and its 200 day moving average price is $71.10. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.28 and a current ratio of 1.37.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the firm posted $0.88 earnings per share. The firm’s quarterly revenue was up 13.4% on a year-over-year basis. As a group, equities research analysts expect that Encompass Health will post 4.1 EPS for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.72%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio is currently 16.22%.

Hedge Funds Weigh In On Encompass Health

Several large investors have recently bought and sold shares of the business. Principal Financial Group Inc. increased its holdings in Encompass Health by 9.1% in the first quarter. Principal Financial Group Inc. now owns 534,270 shares of the company’s stock valued at $44,120,000 after buying an additional 44,612 shares during the last quarter. Benjamin Edwards Inc. increased its holdings in Encompass Health by 17.9% in the first quarter. Benjamin Edwards Inc. now owns 4,582 shares of the company’s stock valued at $378,000 after buying an additional 697 shares during the last quarter. New York State Teachers Retirement System increased its holdings in Encompass Health by 6.8% in the first quarter. New York State Teachers Retirement System now owns 73,166 shares of the company’s stock valued at $6,042,000 after buying an additional 4,670 shares during the last quarter. Horrell Capital Management Inc. increased its holdings in Encompass Health by 0.5% in the first quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock valued at $2,425,000 after buying an additional 147 shares during the last quarter. Finally, Equitable Trust Co. grew its holdings in shares of Encompass Health by 69.4% during the first quarter. Equitable Trust Co. now owns 6,429 shares of the company’s stock worth $531,000 after purchasing an additional 2,634 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.